ONC206 ONC-206 CAS: 1638178-87-6

CAS NO: 1638178-87-6
ONC206 ONC-206
Chemical Name: ONC206
Molecular Formula: C23H22F2N4O
Formula Weight: 408.44
CAS No.: 1638178-87-6
Description Review
Description

ONC206, also known as ONC-206, is a small molecule anti-cancer drug that is currently in preclinical trials. It has shown promise in treating various types of cancer, including solid tumors and hematological malignancies.

Chemical Name

The chemical name of ONC206 is 2-(4-chlorophenyl)-N-(5-methyl-1H-pyrazol-3-yl)quinoline-4-carboxamide.

Molecular Formula

The molecular formula of ONC206 is C21H15ClN4O1.

Formula Weight

The formula weight of ONC206 is 380.82 g/mol.

CAS No.

The CAS number for ONC206 is 1638178-87-6.

Top Ten Keywords and Synonyms from Google

  1. Anti-cancer drug
  2. Preclinical trials
  3. Solid tumors
  4. Hematological malignancies
  5. Carboxamide derivative
  6. Cancer therapy
  7. Pyrazole
  8. Quinoline analogue
  9. Small molecule therapy
  10. Novel therapy

Health Benefits of ONC206

ONC206 is still undergoing preclinical trials, but it has shown promise in treating various types of cancer. In preclinical studies, ONC206 has been shown to inhibit the growth of cancer cells while leaving healthy cells unharmed. This makes it an attractive option for cancer treatment because it may result in fewer side effects than traditional chemotherapy.

Potential Effects

ONC206 has several potential effects, including:

  1. Inhibition of cancer cell growth: ONC206 inhibits the growth of cancer cells.
  2. Induction of apoptosis: ONC206 induces programmed cell death in cancer cells.
  3. Reduction of tumor volume: ONC206 can reduce the size of tumors in preclinical studies.

Product Mechanism

ONC206 works by inhibiting a protein called c-Myc, which plays a role in the growth and proliferation of cancer cells. By inhibiting c-Myc, ONC206 suppresses the growth of cancer cells and induces apoptosis. The c-Myc protein is often overexpressed in cancer cells, making it an attractive target for cancer therapy.

Safety

ONC206 is still undergoing preclinical trials, and its safety profile is not fully understood. Further research is needed to determine the long-term safety of ONC206.

Side Effects

The side effects of ONC206 are not yet known, as it is still in preclinical trials.

Dosing Information

The dosing of ONC206 varies depending on the individual's condition and response to treatment. As it is still in preclinical trials, the optimal dosage has not been determined.

Conclusion

ONC206 is a novel anti-cancer drug that shows promising results in preclinical trials. It works by inhibiting the c-Myc protein, leading to inhibition of cancer cell growth and induction of apoptosis. ONC206 may have fewer side effects than traditional chemotherapy because it specifically targets cancer cells while leaving healthy cells unharmed. While still undergoing preclinical trials, ONC206 offers hope for individuals with various types of cancer. If you are experiencing symptoms of cancer or other health conditions, it is important to seek medical attention and follow the guidance of healthcare professionals.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code